Jumai Abioye

Jumai Abioye, PhD, is an accomplished professional with extensive experience in biotechnology and innovation. Currently, as the Founder of Libratech Inc. and PanAccess Innovations Inc., Jumai Abioye focuses on creating opportunities for innovation in low and middle-income countries and providing accessible testing tools for agriculture and home use, respectively. As a Co-Founder and Vice President of Strategy at Northern RNA Inc., Jumai Abioye drives strategic initiatives and commercial activities while leading efforts to establish a cutting-edge nucleic acid CDMO. With a background that includes key roles at Providence Therapeutics and academic positions at the University of Lethbridge and the University of Ilorin, Jumai Abioye's expertise spans plasmid manufacturing, protein engineering, and educational outreach in STEM. Jumai Abioye holds a PhD in Biomedical Engineering from the University of Glasgow, alongside a Master's degree in Biotechnology and a Bachelor's degree in Microbiology.